Fullerene nano-material for preventing and/or treating aplastic anemia and use thereof

A technology of aplastic and nanomaterials, applied in the field of biomedicine, can solve the problems of increasing the chances of hepatitis, syphilis, and HIV infection, easily causing severe blood transfusion reactions, and reducing the survival period of patients, so as to protect hematopoietic tissue, prevent Reduced hematopoietic function, good biocompatibility

Inactive Publication Date: 2016-08-31
BEIJING FUNAKANG BIOTECH CO LTD
View PDF1 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

⑤Hemorrhagic anemia caused by chronic blood loss caused by long-term hemoptysis and loss of appetite, insufficient intake, resulting in malnutrition and anemia caused by tumor growth and consumption of nutrients in the body
Elimination of the cause is the key to the treatment of anemia, but it also needs to be treated in combination with other methods; general therapy mainly relieves symptoms through proper care, infection prevention, and attention to diet; iron supplementation is mainly for iron deficiency anemia, and for other causes The effect of induced anemia is not obvious, and the action period is relatively long; blood transfusion can quickly alleviate or correct anemia, which is the main measure of symptomatic treatment, but blood transfusion is more likely to cause severe transfusion reactions, increase the chance of hepatitis, syphilis, and HIV infection, and Long-term multiple blood transfusions can also cause iron overload, secondary hemochromatosis, etc. Supplementing rhEPO can accelerate the recovery of bone marrow red blood cell hematopoietic function inhibited by radiotherapy and chemotherapy, and clinical studies have proved that the application of rhEPO can significantly reduce The need for blood transfusion can increase the concentration of hemoglobin, so at present, rhEPO is mainly used to treat anemia
However, recent studies have shown that the application of rhEPO will reduce the survival time of patients, which may be related to the adverse reaction of erythropoietin - thromboembolism

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fullerene nano-material for preventing and/or treating aplastic anemia and use thereof
  • Fullerene nano-material for preventing and/or treating aplastic anemia and use thereof
  • Fullerene nano-material for preventing and/or treating aplastic anemia and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0089] Example 1, the effect of water-soluble gadolinium hydroxylated metal fullerene in the treatment of anemia at the living level

[0090] Animal model: ICR 5-week-old female mice were selected and randomly divided into 3 groups, 6 mice in each group, corresponding to Control group, AA1 group and AA2 group respectively.

[0091] 1. Chemotherapy drugs induce aplastic anemia in mice

[0092] Control group: the same volume of normal saline was used instead of the drugs injected in the AA group, and intraperitoneally injected into the mice, and the other treatment methods were the same as those in the AA group.

[0093] Group AA: Drugs were injected into the mice through intraperitoneal cavity, the specific doses were: cyclophosphamide 80 mg / kg body weight / time, busulfan 20 mg / kg body weight / time.

[0094] Cultivate the mice for 2 to 3 days, observe the state of the mice, and measure the relevant indicators of the mice, such as RBC, HGB, WBC, etc. After the data is stable, it ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a fullerene nano-material for preventing and/or treating aplastic anemia and a use thereof. The use of the fullerene nano-material comprises 1, improving a leukocyte generation amount, 2, improving an erythrocyte generation amount, 3, improving a hemoglobin generation amount, 4, improving a platelet generation amount, 5, improving a hematocrit value, 6, improving a mean corpuscular volume, 7, improving mean corpuscular hemoglobin content or 8, improving a mean corpuscular hemoglobin concentration. The fullerene and/or metallofullerene nanometer material can be prepared through a simple and fast method, has good biocompatibility, has no toxic or side effects on organisms and can be used for related hemopoietic tissue through blood circulation. The fullerene and/or metallofullerene nanometer material has a certain protection and/or restoration effect on anaemia and related diseases and has obvious anaemia-related index recovery effects. The fullerene and/or metallofullerene nanometer material has stable properties and can protect and/or repair cells, blood and marrow.

Description

technical field [0001] The invention relates to a fullerene nanometer material for preventing and / or treating aplastic anemia and an application thereof, belonging to the field of biomedicine. Background technique [0002] According to the statistics of the World Health Organization, there are about 3 billion people with varying degrees of anemia in the world, and tens of millions of people die every year due to various diseases caused by anemia. In addition, the population probability of suffering from anemia in my country is higher than that of Western countries. Among the people suffering from anemia, women are significantly higher than men, and the elderly and children are higher than young and middle-aged people. About 30% to 40% of infants and young children suffer from anemia, and pregnant women up to 48%. Anemia is one of the most important diseases that threaten human health in the world and in our country. [0003] The so-called anemia means that the total amount ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/10A61K47/04A61P7/06
CPCA61K47/10A61K47/02
Inventor 王春儒甄明明贾旺
Owner BEIJING FUNAKANG BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products